JMT101: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

4

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Phase 3 1

Conditions being studied

Condition	Trials
Harboring EGFR Sensitive Mutations NSCLC	1
Locally Advanced or Metastatic Non-squamous NSCLC	1
Lung cancer	1
Previously Untreated Systematically NSCLC	1

Recruiting trials involving JMT101

A Clinical Study of JMT101 in Combination With Osimertinib Versus Osimertinib Alone as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Sensitive Mutations
NCT06735391 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve JMT101?

1 recruiting trial across 4 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.